Skip to main content

Year: 2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

STAFFORD, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following global update on FLAMINGO-01. Flamingo-01 Progress to Date The Company has achieved a major milestone by screening over 1,000 patients in Flamingo-01, continuing its screening rate of approximately 150 patients per quarter or the equivalent of 600 patients per year in approximately 40 US sites and 100 EU sites for a total of 140 active sites. The Company is considering a strategy to continue enrolling in both the HLA-A*02 and non-HLA-A*02 arms until interim analyses are conducted and the appropriate...

Continue reading

Osisko Metals Announces $32.5 Million Private Placement with Strategic Investors

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce that it expects to complete a non-brokered private placement with certain strategic investors for an aggregate of approximately 67,666,666 common shares of the Company (the “Common Shares“) at an offering price of $0.48 per Common Share for aggregate gross proceeds to the Company of approximately $32,480,000 (the “Private Placement”). The Private Placement is expected to include subscriptions from certain strategic investors, including:Hudbay Minerals Inc.: 29,166,666 Common Shares for gross proceeds of $14,000,000; Agnico Eagle...

Continue reading

FERRARI RENEWS ITS PARTNERSHIP WITH PHILIP MORRIS INTERNATIONAL

Maranello (Italy), December 3, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or “the Company”) announced today that Ferrari S.p.A., its wholly-owned Italian subsidiary, has renewed and strengthened its multi-year partnership with Philip Morris International (NYSE: PM). Under the agreement – signed today and taking effect on January 1, 2026 – Philip Morris International becomes a Premium Partner of Scuderia Ferrari HP and a Series Partner of the Ferrari Challenge Trofeo Pirelli, continuing a collaboration that has spanned more than 50 years.  For further information:Media Relationstel.: +39 0536 949337Email: media@ferrari.comAttachmentCS_FNV_PMI_ENG

Continue reading

FactSet and Arcesium Debut Tech To Unite Front, Middle, and Back Office Workflows for Asset Owners and Managers

Amid Industry-Wide Battle Against Opacity, FactSet and Arcesium Deliver End-to-End Unification of Asset Management Lifecycle Across Public, Private, and Alternative Markets NORWALK, Conn., Dec. 03, 2025 (GLOBE NEWSWIRE) — FactSet (NYSE:FDS) (NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, and Arcesium, a leading global financial technology firm for the investment industry, today announced a strategic partnership to deliver a unified investment management offering designed to seamlessly integrate front, middle, and back office asset management workflows across public, private, and alternative markets. This partnership addresses the growing demand for solutions that unify workflows, connect fragmented data, and enable firms to navigate the increasing complexity of modern investing. “Feedback from...

Continue reading

IREN Announces Pricing of Ordinary Shares Offering to Fund the Repurchase of Convertible Notes

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced the pricing of a registered direct offering of 39,699,102 ordinary shares at a price of $41.12 per share (the “Offering”) to a limited number of purchasers. The Offering is being made pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The aggregate gross proceeds from the Offering approximate the aggregate cash consideration payable in connection with the Repurchase. In conjunction with any Repurchase of the Existing 2029 Convertible Notes (initial conversion price of $13.64) and Existing 2030 Convertible Notes (initial conversion price of $16.81), the principal amount of debt outstanding under the Existing Convertible Notes will be reduced accordingly and will be extinguished and, accordingly, will no longer...

Continue reading

Virtune announces that selected crypto ETPs are now available for commission-free buying and monthly savings plans on Smartbroker

Frankfurt, 3 December 2025 – Virtune today announces that it has entered a partnership with Smartbroker as a Preferred Partner where a selection of its crypto exchange-traded products (ETP) – including the Virtune Coinbase 50 Index ETP, the Virtune Crypto Altcoin Index ETP, the Virtune Stablecoin Index ETP as well as its Bitcoin, XRP, Sui and Solana ETPs – are now available for commission-free buying and monthly savings plans on the Smartbroker platform. This partnership makes it easier than ever for investors to set up long-term and commission-free monthly savings plans in Bitcoin and other leading crypto assets through Smartbroker. By Virtune becoming a preferred partner to Smartbroker, the partnership between the two firms will be further strengthened. This may include joint educational initiatives such as webinars,...

Continue reading

Yuanbao Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 03, 2025 (GLOBE NEWSWIRE) — Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial and Operational HighlightsTotal revenues in the third quarter of 2025 were RMB1,157.9 million (US$162.6 million), representing a 33.6% year-over-year increase from RMB866.8 million in the same period of 2024. Net income in the third quarter of 2025 was RMB370.4 million (US$52.0 million), representing a 51.3% year-over-year increase from RMB244.8 million in the same period of 2024. Net income margin in the third quarter of 2025 was 32.0%, compared with 28.2% in the same period of 2024. Net operating cash inflow in the third quarter of 2025 was...

Continue reading

Ensurge Micropower ASA – Extraordinary General Meeting held on 3 December 2025

Oslo, 3 December 2025  An Extraordinary General Meeting in Ensurge Micropower ASA (the “Company”) was held today as an electronic meeting. All items on the agenda were adopted in accordance with the proposals of the Board of Directors in the notice to the Extraordinary General Meeting, including, among other things, the issuance of 27,433,079 tranche 2 shares in the private placement announced on 9 November 2025, a subsequent offering of up to 22,222,222 offer shares to existing shareholders not participating in such private placement (more details to follow in a separate stock exchange announcement), and the issuance of 67,934,000 warrants to Corning Research & Development Corporation, each warrant with an exercise price of NOK 1.50.  The minutes from the Extraordinary General Meeting will be made available on the Company’s...

Continue reading

Kaldalón hf.: Manager’s transaction

Attached is a notification regarding the transaction of a party closely related to a board member in accordance with Article 19 of MAR, cf. Icelandic Act No. 60/2021. The transaction concerns the purchase by IREF ehf. of 5,185,000 shares in Kaldalón from Loran ehf. on the one hand and 5,185,000 shares in Kaldalón from Premier eignarhaldsfélag ehf. on the other hand, or a total of 10,370,000 shares. The buyer of the shares, IREF ehf., is equally owned by the sellers of the shares.AttachmentTilkynning – IREF ehf kaupir 10.370.000 hluti í KALD.IC af Loran 5.185.000 og Premier 5.185.000 – 02.02.2025 (1)

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.